Johns Hopkins University, Maryland, United States
Dr. Jamie Spangler earned a Bachelor of Science degree in Biomedical Engineering at Johns Hopkins University and went on to earn a Ph.D. in Biological Engineering at MIT. After completing a postdoctoral fellowship at Stanford University School of Medicine, Dr. Spangler launched her independent research group at Johns Hopkins University in July 2017, jointly between the departments of Biomedical Engineering and Chemical & Biomolecular Engineering. Her lab, located in the Translational Tissue Engineering Center at the School of Medicine, applies structural and mechanistic insights to re-engineer existing proteins and design new proteins that therapeutically modulate the immune response. In particular, her group is interested in engineering immune molecules such as cytokines, growth factors, and antibodies for targeted treatment of diseases such as cancer and autoimmune disorders.
Disclosure information not submitted.
Next Generation Protein Therapeutics
Tuesday, February 6, 2024
3:00 PM – 5:00 PM EST
Engineering cytokine/antibody fusion proteins as targeted immunotherapeutics
Tuesday, February 6, 2024
3:00 PM – 3:30 PM EST